Practices, attitudes, and knowledge about Crohn's disease and smoking cessation among gastroenterologists

被引:4
作者
Nulsen, Benjamin [1 ]
Sands, Bruce E. [2 ]
Shah, Brijen J. [2 ]
Ungaro, Ryan C. [2 ]
机构
[1] Icahn Sch Med Mt Sinai, Dept Med, One Gustave L Levy Pl,Box 1118, New York, NY 10029 USA
[2] Icahn Sch Med Mt Sinai, Dr Henry D Janowitz Div Gastroenterol, New York, NY 10029 USA
关键词
Crohn's disease; smoking cessation; surveys and questionnaires; tobacco use cessation; quality improvement; INFLAMMATORY-BOWEL-DISEASE; EXTRAINTESTINAL MANIFESTATIONS; QUALITY INDICATORS; ULCERATIVE-COLITIS; BIOLOGIC ERA; QUIT SMOKING; MANAGEMENT; RECURRENCE; BEHAVIOR; RISK;
D O I
10.1097/MEG.0000000000001010
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objective Cigarette smoking is one of the most important, modifiable environmental factors in Crohn's disease (CD) and screening for tobacco use is an official recommendation and quality measure in the care of CD patients. The objective of this study was to learn more about gastroenterologists' practices, opinions, and knowledge in this area. Patients and methods A 15 question survey was sent through email to two national gastroenterology distribution lists. Questions were written in multiple choice formats and were designed to collect information about gastroenterologists' practices, attitudes, and knowledge regarding smoking cessation in CD patients. Responses were stratified by practice setting, experience, and inflammatory bowel disease-focus. Responses were anonymous and were collected in a secure, online database. Results A total of 141 respondents completed the survey. Overall, 89% of participants screened their CD patients for smoking more than 75% of the time. In all, 62% provided smoking cessation counseling more than 75% of the time. Overall, 94% of respondents felt comfortable discussing the benefits of smoking cessation with their patients. In all, 56% felt comfortable discussing smoking cessation strategies with their patients. Overall, 88% of respondents agreed that gastroenterologists should provide smoking cessation counseling; however, 43 and 11% agreed that the gastroenterologist should be the primary counselor and primary prescriber of cessation-related pharmacotherapy, respectively. Conclusion Surveyed gastroenterologists agree that smoking cessation is an important part of the care of CD patients and this is reflected in their screening practices. Counseling occurs irregularly and many gastroenterologists do not feel comfortable discussing cessation strategies. Future guidelines should provide further guidance on the gastroenterologist's role in smoking cessation counseling for CD patients. Copyright (C) 2018 Wolters Kluwer Health, Inc. All rights reserved.
引用
收藏
页码:155 / 160
页数:6
相关论文
共 50 条
  • [31] A survey of Canadian gastroenterologists about the use of methotrexate in patients with Crohn's disease
    Chande, N
    Ponich, T
    Gregor, J
    [J]. CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2005, 19 (09) : 553 - 558
  • [32] Smoking cessation knowledge, attitude and practices among tuberculosis physicians: A qualitative study
    Harutyunyan, Arusyak
    Abrahamyan, Armine
    Grigoryan, Zaruhi
    Hayrumyan, Varduhi
    Truzyan, Nune
    Petrosyan, Varduhi
    [J]. TOBACCO PREVENTION & CESSATION, 2020, 6 : 1 - 9
  • [33] Attitudes, beliefs, and practices regarding smoking and smoking cessation among African-American physicians and dentists
    Hill, HA
    Braithwaite, RL
    [J]. JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 1997, 89 (11) : 745 - 751
  • [34] The effect of a multidisciplinary approach for smoking cessation in patients with Crohn's disease: Results from an observational cohort study
    Santus, Pierachille
    Radovanovic, Dejan
    Raiteri, Davide
    Pini, Stefano
    Spagnolo, Giuseppe
    Maconi, Giovanni
    Rizzi, Maurizio
    [J]. TOBACCO INDUCED DISEASES, 2020, 18
  • [35] Providers' smoking cessation attitudes and practices for older patients
    Kviz, FJ
    Clark, MA
    Slezak, JA
    Davis, AM
    [J]. BEHAVIORAL MEDICINE, 1999, 25 (02) : 53 - 61
  • [36] Ivory Coast physician's knowledge and attitudes about smoking in patients with tuberculosis
    Daix, A. T. J.
    Bakayoko-Yeo, A. S.
    Kone, Z.
    Samake, K.
    Coulibaly, G.
    Touhon, O. A.
    Domoua, K. M. S.
    [J]. REVUE DES MALADIES RESPIRATOIRES, 2015, 32 (05) : 513 - 518
  • [37] Attitudes and Knowledge of Australian Gastroenterologists Around the Use of Medicinal Cannabis for Inflammatory Bowel Disease
    Benson, Melissa J.
    Abelev, Sarah, V
    Corte, Crispin J.
    Connor, Susan J.
    McGregor, Iain S.
    [J]. CROHNS & COLITIS 360, 2020, 2 (02)
  • [38] Does active smoking really influence the course of Crohn's disease? A retrospective observational study
    Zabana, Yamile
    Garcia-Planella, Esther
    Van Domselaar, Manuel
    Manosa, Miriam
    Gordillo, Jordi
    Lopez San Roman, Antonio
    Cabre, Eduard
    Domenech, Eugeni
    [J]. JOURNAL OF CROHNS & COLITIS, 2013, 7 (04) : 280 - 285
  • [39] Impact of Maternal Smoking, Offspring Smoking, and Genetic Susceptibility on Crohn's Disease and Ulcerative Colitis
    Hu, Linmin
    Wu, Siqing
    Shu, Yuelong
    Su, Kai
    Wang, Chunliang
    Wang, Danni
    He, Qiangsheng
    Chen, Xinyu
    Li, Wenjing
    Mi, Ningning
    Xie, Peng
    Zhao, Jinyu
    Zhang, Shiyong
    Yuan, Jinqiu
    Xiang, Jianbang
    Xia, Bin
    [J]. JOURNAL OF CROHNS & COLITIS, 2024, 18 (05) : 671 - 678
  • [40] Effects of Light Smoking Consumption on the Clinical Course of Crohn's Disease
    Seksik, Philippe
    Nion-Larmurier, Isabelle
    Sokol, Harry
    Beaugerie, Laurent
    Cosnes, Jacques
    [J]. INFLAMMATORY BOWEL DISEASES, 2009, 15 (05) : 734 - 741